Mr. Svencer is an Operations and Development Executive with strong analytical, organizational, technology, leadership, and relationship building competencies. He has been with Augmenix since 2009. He was previously at Brontes Technologies, a 3M Company, Confluent Surgical, an Incept LLC Company, and Analogic Corporation. He earned a BSME and a MS in Engineering Management from Tufts University.
Started in 2007, Augmenix is focused on improving the outcomes of radiotherapy through the use of absorbable hydrogels. The company is using this technology to develop products that decrease unintended radiation damage to normal organs during radiation therapy and to mark soft tissue.